OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Drug Policy is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Publisher's Note	248
Incarceration history, antiretroviral therapy, and stigma: A cross-sectional study of people with HIV who inject drugs in St. Petersburg, Russia	167
Opioid prescribing restrictions and opioid use among the Louisiana Medicaid population	94
Doing more with less: A proposal to advance cigarette packaging regulations in the United States	82
A matter of craving–An archeology of relapse prevention in Swedish addiction treatment	75
Editorial Board	63
Editorial Board	61
Editorial Board	58
Bridging the gap: An environmental scan of post-overdose program features and evaluation measures	57
Editorial Board	54
Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States	54
Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States	53
Older age at smoking initiation predicts successful cessation in adults who smoke: A prospective study	51
A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of gabapentin in the United States, 2016–2024	48
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework	48
International property rights for Cannabis landraces and terroir products. The case of Moroccan Cannabis and hashish	48
Social-spatial network structures among young urban and suburban persons who inject drugs in a large metropolitan area	47
Increased solitary drug use during COVID-19: An unintended consequence of social distancing	47
Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers	46
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis	45
Identifying barriers and enablers to opt-out hepatitis C virus screening in provincial prisons in Quebec, Canada: A multilevel, multi-theory informed qualitative study with correctional and healthcare	45
Ecological dimensions of cannabis regulation in the Rif, Morocco	44
Editorial Board	44
The introduction of fentanyl on the US–Mexico border: An ethnographic account triangulated with drug checking data from Tijuana	43
The social-structural contexts of cannabis consumption and harm reduction among young Nigerian women	42

Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts	41
Quasi-experimental study on the impact of local smoke-free policies on smoking among Indonesian adults: Evidence from repeated national health surveys	40
‘Choice’ of social media platform or encrypted messaging app to buy and sell illegal drugs	39
A content analysis of cannabis edibles package marketing in the United States	39
Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia	38
Trends in the use of cannabis products in Canada and the USA, 2018 – 2020: Findings from the International Cannabis Policy Study	38
The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial	38
Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada	38
Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019–2020	37
Likelihood of using a harm reduction vending machine among rural people who inject drugs in Appalachian Kentucky	36
Cannabis reduction among adolescents as spillover from successful tobacco control	35
Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis	35
‘Pretty in Pink’ and ‘Girl Power’: An analysis of the targeting and representation of women in alcohol brand marketing on Facebook and Instagram	35
Putting tendencies and trajectories to work: useful tools for engaging with accounts of change and recovery?	35